Retos sobre la carga epidemiológica y económica para diabetes e hipertensión en México

Abstract

OBJECTIVE To analyze the epidemiological and economic burden of the health services demand due to diabetes and hypertension in Mexico.METHODS Evaluation study based on a time series study that had as a universe of study the assured and uninsured population that demands health services from the three main institutions of the Health System in Mexico: The Health Department, the Mexican Institute of Social Security, and Institute of Services and Social Security for State Workers. The financing method was based on instrumentation and consensus techniques for medium case management. In order to estimate the epidemiological changes and financial requirements, a time series of observed cases for diabetes and hypertension 1994–2013 was integrated. Probabilistic models were developed based on the Box-Jenkins technique for the period of 2013–2018 with 95% confidence intervals and p < 0.05.RESULTS Comparing results from 2013 versus 2018, in the five regions, different incremental trends of 14%–17% in epidemiological changes and 58%-66% in the economic burden for both diseases were observed.CONCLUSIONS If the risk factors and the different models of care remained as they currently are in the three institutions analyzed, the financial consequences would be of greater impact for the Mexican Institute of Social Security, following in order of importance the Institute of Services and Social Security for State Workers and lastly the Health Department. The financial needs for both diseases will represent approximately 13%–15% of the total budget allocated to the uninsured population and 15%–17% for the population insured depending on the region.

Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico

“…The economic gain of this transition in the care model would generate high benefits in reducing the economic burden of damages attributable to diabetes and hypertension. Evidence from simulation models shows that increasing the resources in promotion and prevention in 30% could produce potential savings of 70–80% of the current economic burden for diabetes and hypertension [ 54 , 55 ].…”

Cardiovascular Risk Factors and Social Development Index

“…Most of the burden of CVD has been explained by a set of traditional risk factors that affect both men and women (2). In Mexico, as in other middle-income countries, cardiovascular mortality, as well as, their main traditional and novel risk factors have become a major health problem, causing an economic burden and being an important source of disability in young adults (3)(4)(5)(6)(7).…”

Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019

“…In addition to human suffering, SAH has important financial consequences for health systems [ 10 , 20 , 21 ]. In the USA, where the prevalence of SAH is 36.9%, it is estimated that in 2018 the annual medical costs of hypertensive patients were US$ 131 billion higher than those of non-hypertensive patients [ 22 ].…”